DCGO Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

0.644

Open

0.644

VWAP

0.64

Vol

62.28K

Mkt Cap

63.08M

Low

0.632

Amount

39.64K

EV/EBITDA(TTM)

--

Total Shares

97.81M

EV

-3.54M

EV/OCF(TTM)

-0.06

P/S(TTM)

0.18

DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports.

Show More

Events Timeline

(ET)

2025-11-10

16:08:04

DocGo projects FY26 revenue between $280M and $300M, below consensus estimate of $317.78M.

2025-11-10

16:07:28

DocGo updates FY25 revenue forecast to a range of $315M-$320M, down from $300M-$330M.

2025-11-10

16:06:23

DocGo Announces Q3 EPS of 28 Cents Compared to 5 Cents Last Year

2025-10-20 (ET)

2025-10-20

17:25:36

DocGo purchases virtual healthcare platform SteadyMD

2025-08-07 (ET)

2025-08-07

16:50:16

DocGo backs FY25 revenue view of $300M-$330M, consensus $.

2025-08-07

16:48:31

DocGo reports Q2 EPS (11c), consensus (23c)

News

Businesswire

03-02Businesswire

DocGo to Release Q4 and Full Year 2025 Financial Results on March 16, 2025

Newsfilter

03-02Newsfilter

DocGo to Release Q4 and Full Year 2025 Financial Results and Host Conference Call

Businesswire

02-17Businesswire

DocGo CEO to Attend Health Conference

Newsfilter

02-17Newsfilter

DocGo CEO to Attend Health Conference

Businesswire

01-27Businesswire

DocGo Expands Clinical Workforce to Meet Growing Demand

Businesswire

01-05Businesswire

DocGo CFO to Speak at 28th Annual Needham Growth Conference, Advancing Mobile Health Services

4 Analyst Rating

Wall Street analysts forecast DCGO stock price to rise

3 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

1.50

Averages

3.13

High

4.00

Current: 0.000

Low

1.50

Averages

3.13

High

4.00

Canaccord

Hold

downgrade

AI Analysis

2025-11-12

Reason

Canaccord

Price Target

AI Analysis

2025-11-12

downgrade

Hold

Reason

Canaccord lowered the firm's price target on DocGo to $1.50 from $1.60 and keeps a Hold rating on the shares. The firm said while the price target does portend upside from current levels they believe that there is some value to be had for DocGo operations however, they do not see multiple expansion from a fundamental perspective until there is meaningful adj-EBITDA loss improvement.

Canaccord

Richard Close

Hold

maintain

2025-08-21

Reason

Canaccord

Richard Close

Price Target

2025-08-21

maintain

Hold

Reason

Canaccord analyst Richard Close raised the firm's price target on DocGo to $1.60 from $1.45 and keeps a Hold rating on the shares. The firm said DocGo showed some progress with its core business in 2Q as it works to replace the waning migrant services contract(s) that should be largely wound down entering 2H;however, there is much work to be done to rightsize the organization while also ramping up new business.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for DCGO

Unlock Now

Valuation Metrics

The current forward P/E ratio for DocGo Inc (DCGO.O) is -2.19, compared to its 5-year average forward P/E of 30.18. For a more detailed relative valuation and DCF analysis to assess DocGo Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

30.18

Current PE

-2.19

Overvalued PE

64.79

Undervalued PE

-4.43

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

9.41

Current EV/EBITDA

-1.14

Overvalued EV/EBITDA

17.34

Undervalued EV/EBITDA

1.48

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

1.06

Current PS

0.31

Overvalued PS

1.68

Undervalued PS

0.44

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

list of strong buy stocks under $3.00

Intellectia · 94 candidates

Price: <= $3.00Analyst Consensus: Strong Buy

Ticker

Name

Market Cap$

Akari Therapeutics PLC

9.32M

Plus Therapeutics Inc

52.05M

Reviva Pharmaceuticals Holdings Inc

38.21M

Intensity Therapeutics Inc

23.85M

Mereo BioPharma Group PLC

84.34M

Atossa Therapeutics Inc

77.93M

let change to 10x potential

Intellectia · 18 candidates

Price: <= $1.00Relative Vol: >= 0.800Beta: HighRiskWeek Price Change Pct: $-5.00 - $100.00

Ticker

Name

Market Cap$

Advantage Solutions Inc

260.01M

Ring Energy Inc

203.08M

Fury Gold Mines Ltd

136.18M

DocGo Inc

83.31M

PLAYSTUDIOS Inc

79.38M

Cheche Group Inc

69.46M

my source said it’s trading below $1

Intellectia · 38 candidates

Price: <= $1.00Weekly Average Turnover: >= 500,000Target Price Upside Potential: MoreAbovePrice

Ticker

Name

Market Cap$

Strive Inc

1.11B

Canaan Inc

498.64M

Datavault AI Inc

433.82M

DeFi Technologies Inc

366.70M

Kindly MD Inc

283.65M

TRX Gold Corp

271.29M

Whales Holding DCGO

Trading Trends

People Also Watch

Frequently Asked Questions

What is DocGo Inc (DCGO) stock price today?

The current price of DCGO is 0.63225 USD — it has decreased -2.02

What is DocGo Inc (DCGO)'s business?

DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports.

What is the price predicton of DCGO Stock?

Wall Street analysts forecast DCGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DCGO is3.13 USD with a low forecast of 1.50 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is DocGo Inc (DCGO)'s revenue for the last quarter?

DocGo Inc revenue for the last quarter amounts to 70.81M USD, decreased -48.94

What is DocGo Inc (DCGO)'s earnings per share (EPS) for the last quarter?

DocGo Inc. EPS for the last quarter amounts to -0.28 USD, decreased -660.00

How many employees does DocGo Inc (DCGO). have?

DocGo Inc (DCGO) has 3404 emplpoyees as of March 11 2026.

What is DocGo Inc (DCGO) market cap?

Today DCGO has the market capitalization of 63.08M USD.